Clinical Chemistry Market By Product (Analyzers Market, Reagents Market), By Test (Basic Metabolic Panels, Electrolyte Panels, Liver Panels, Lipid Profiles, Renal Profiles, Thyroid Function Panels), By End User (Academic Research Centers, Diagnostic Laboratories, Hospitals), Industry Size, Growth, Share And Forecast To 2022
Key Findings
Clinical chemistry is a type of clinical pathology, clinical biochemistry or medical biochemistry and this market is driving by the various factors such as- Increasing number of chronic disorder, growing laboratory automation, increasing reagent rental agreements, increasing generic population and increasing healthcare expenditure. The cases of chronic diseases such diabetes, heart diseases and depression are continuously increasing and it is driving the market. Specially in North America approx 133 million of people are suffering with the chronic diseases in 2014 and it is projected that during the forecast period the number of chronic diseases patients will increase up to 160 million approx. As per this calculation about half of the chronic disorder patients are adults and nearly 10% of the children between 5 to 20 years were reported by their parents. In 2014, death rate is 6 out of 10 in U.S. due to chronic diseases such as- heart diseases, stroke and cancer are the major reasons for the deaths. Some of the major restraints of the clinical chemistry market are high capital investment and high entry barrier. The opportunities if the market is- untapped potential of emerging economies and increasing technological advancements. Challenges faced by the global clinical chemistry market are- strict government regulation and policies for medical devices and lack of awareness. The global clinical chemistry market is expected to grow at the 5.93% CAGR during the forecast period 2016-2022.
Market Segment Insight
The global clinical chemistry market is segmented into three parts such as- by product, by test and by end user. On the basis of product it is divided into three parts such as- analyzers, reagents and others. On the basis of test it is divided into seven parts such as- basic metabolic panel, electrolyte panels, liver panel, lipid panels, renal profiles, thyroid function panels and specialty chemical tests. And on the basis of end user it is divided into four parts such as- academic research centers, diagnostic laboratories, hospitals and other end user. In the test segment its sub segment basic metabolic panel test is dominating the test segment in the clinical chemistry market in which the demand is increasing for preventive medicines & lifestyle induced disorders. During the forecast period lipid profile test is predicted to be the fastest growth in the clinical chemistry market due to increasing prevalence rate of cardiovascular diseases among the population. On the basis of end users the sub segment diagnostic laboratories is dominating the clinical chemistry market due to increasing number of in-vitro diagnostic tests, increasing awareness among the population for the healthcare, growing aging population & chronic disorders and the criminal activities are rising the demand of diagnostic laboratory testing in the global chemistry market.
Regional Insight
On the basis of geography the clinical chemistry market is divided into North America, Europe, Asia pacific, Middle East and Africa, and Latin America.In 2014,North America is the region which is dominating the market revenue share over 60% of the global clinical chemistry market followed by Asia pacific and Europe due to the new technological advancements in medical device market, a very well developed infrastructure in the healthcare market and also a wide regulatory framework are the few factors those are contributors to the North America for the highest revenue share. Apart from this during the forecast period it is predicted that Asia Pacific region is the next highest growing market globally due to the growing demand of rising economic conditions, automation market, and the awareness among patients is growing for the healthcare. China is the great contributor to grow in the clinical chemistry market owing to high healthcare expenditure which is continuously increasing. Even in 2015 China’s total healthcare expenditure is 11.8% in a year. During the forecast period it is accounted that China will reach $900 billion approx due to due to increasing generic population as well as medical tourism. In the BRIC countries the clinical chemistry markets are developing and during the forecast period it is accounted to grow with the highest CAGR.
Competitive Insights
Some of the key players of the industries are- ABBOTT LABORATORIES, BECKMAN COULTER, INC., DANAHER CORPORATION, ELITECH GROUP, F. HOFFMANN-LA ROCHE LTD., HITACHI LTD., HORIBA, LTD., JOHNSON & JOHNSON, MINDRAY MEDICAL INTERNATIONAL LIMITED, NOVA BIOMEDICAL CORPORATION, ORTHO-CLINICAL DIAGNOSTICS, INC., RANDOX LABORATORIES LTD., ROCHE, SIEMENS AG, THERMO FISHER SCIENTIFIC INC. and more.
Acquisitions, innovations, and mergers are the key strategies which help to increase the market share of the company. Recently one of the key market player of clinical chemistry market Abbott Laboratories on 28th April 2016 has announce to acquire St. Jude Medical which is the medical device maker company. Similarly on 31st August 2015 Danaher Corporation has announced to acquire Pall Corporation.
CHAP 1. METHODOLOGY & SCOPE 14
1.1. RESEARCH METHODOLOGY 14
1.2. RESEARCH SCOPE & ASSUMPTIONS 14
1.3. LIST OF DATA SOURCES 14
CHAP 2. EXECUTIVE SUMMARY 15
2.1. GLOBAL CLINICAL CHEMISTRY MARKET SUMMARY & KEY BUYING CRITERIA 15
2.2. GLOBAL CLINICAL CHEMISTRY MARKET OUTLOOK 15
2.3. MARKET SEGMENTATION ANALYSIS 15
2.4. MARKET SIZE AND GROWTH PROSPECTS 2012-2022 15
2.5. GLOBAL CLINICAL CHEMISTRY MARKET VALUE CHAIN ANALYSIS 15
2.6. VENDOR LANDSCAPE 15
CHAP 3. GLOBAL CLINICAL CHEMISTRY MARKET 16
3.1. MARKET DRIVER ANALYSIS 16
3.2. MARKET RESTRAINT ANALYSIS 16
3.3. KEY OPPORTUNITIES 16
3.4. CHALLENGES 16
3.4.2. LACK OF AWARENESS 16
CHAP 4. INDUSTRY ANALYSIS 17
4.1. GLOBAL CLINICAL CHEMISTRY MARKET– PORTER’S FIVE FORCE MODEL 17
4.2. GLOBAL CLINICAL CHEMISTRY MARKET– PESTEL ANALYSIS 17
4.3. GLOBAL CLINICAL CHEMISTRY MARKET- GAP ANALYSIS 17
CHAP 5. GLOBAL CLINICAL CHEMISTRY MARKET BY PRODUCT 2012-2022 ($ MILLION) 18
5.1. GLOBAL CLINICAL CHEMISTRY ANALYZERS MARKET 2012-2022 ($ MILLION) 18
5.2. GLOBAL CLINICAL CHEMISTRY REAGENTS MARKET 2012-2022 ($ MILLION) 18
5.3. GLOBAL CLINICAL CHEMISTRY OTHER PRODUCTS MARKET 2012-2022 ($ MILLION) 18
CHAP 6. GLOBAL CLINICAL CHEMISTRY MARKET BY TEST 2012-2022 ($ MILLION) 19
6.1. GLOBAL CLINICAL CHEMISTRY BASIC METABOLIC PANELS 19
6.2. GLOBAL CLINICAL CHEMISTRY ELECTROLYTE PANELS MARKET 2012-2022 ($ MILLION) 19
6.3. GLOBAL CLINICAL CHEMISTRY LIVER PANELS MARKET 2012-2022 ($ MILLION) 19
6.4. GLOBAL CLINICAL CHEMISTRY LIPID PROFILES MARKET 2012-2022 ($ MILLION) 19
6.5. GLOBAL CLINICAL CHEMISTRY RENAL PROFILES MARKET 2012-2022 ($ MILLION) 19
6.6. GLOBAL CLINICAL CHEMISTRY THYROID FUNCTION PANELS MARKET 2012-2022 ($ MILLION) 19
6.7. GLOBAL CLINICAL CHEMISTRY SPECIALTY CHEMICAL TESTS MARKET 2012-2022 ($ MILLION) 19
CHAP 7. GLOBAL CLINICAL CHEMISTRY MARKET BY END USER 2012-2022 ($ MILLION) 20
7.1. GLOBAL CLINICAL CHEMISTRY ACADEMIC RESEARCH CENTERS MARKET 2012-2022 ($ MILLION) 20
7.2. GLOBAL CLINICAL CHEMISTRY DIAGNOSTIC LABORATORIES MARKET 2012-2022 ($ MILLION) 20
7.3. GLOBAL CLINICAL CHEMISTRY HOSPITALS MARKET 2012-2022 ($ MILLION) 20
7.4. GLOBAL CLINICAL CHEMISTRY OTHER END USERS MARKET 2012-2022 ($ MILLION) 20
CHAP 8. GLOBAL CLINICAL CHEMISTRY MARKET, REGIONAL OUTLOOK 2012-2022 ($ MILLION) 21
8.1. GLOBAL CLINICAL CHEMISTRY MARKET BY REGION 2012-2022 ($ MILLION) 21
8.2. NORTH AMERICA 21
8.2.1. NORTH AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 21
8.2.2. NORTH AMERICA MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 21
8.2.3. NORTH AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 21
8.2.3.1. U.S. 21
8.2.3.1.1. U.S. MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 21
8.2.3.1.2. U.S. MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 21
8.2.3.2. CANADA 21
8.2.3.2.1. CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 21
8.2.3.2.2. CANADA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 21
8.3. EUROPE 21
8.3.1. EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 21
8.3.2. EUROPE MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 21
8.3.3. EUROPE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 21
8.3.3.1. GERMANY 21
8.3.3.1.1. GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 22
8.3.3.1.2. GERMANY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 22
8.3.3.2. UK 22
8.3.3.2.1. UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 22
8.3.3.2.2. UK MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 22
8.3.3.3. FRANCE 22
8.3.3.3.1. FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 22
8.3.3.3.2. FRANCE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 22
8.3.3.4. SPAIN 22
8.3.3.4.1. SPAIN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 22
8.3.3.4.2. SPAIN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 22
8.3.3.5. REST OF EUROPE 22
8.3.3.5.1. RUSSIA MARKET ESTIMATES AND FORECAST2012-2022($MILLION) 22
8.3.3.5.2. OTHERS MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022($MILLION) 22
8.4. ASIA PACIFIC 22
8.4.1. ASIA PACIFIC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 22
8.4.2. ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 22
8.4.3. ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 22
8.4.3.1. CHINA 22
8.4.3.1.1. CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 23
8.4.3.1.2. CHINA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 23
8.4.3.2. INDIA 23
8.4.3.2.1. INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 23
8.4.3.2.2. INDIA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 23
8.4.3.3. JAPAN 23
8.4.3.3.1. JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 23
8.4.3.3.2. JAPAN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($MILLION) 23
8.4.3.4. OTHERS 23
8.4.3.4.1. OTHER MARKET ESTIMATES AND FORECASTS 2012-2022($MILLION) 23
8.4.3.4.2. OTHER MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022($MILLION) 23
8.5. MIDDLE EAST & AFRICA 23
8.5.1. MIDDLE EAST & AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 23
8.5.2. MIDDLE EAST & AFRICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 23
8.6. LATIN AMERICA 23
8.6.1. LATIN AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 23
8.6.2. LATIN AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 23
8.6.2.1. BRAZIL 23
8.6.2.1.1. BRAZIL MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 24
8.6.2.1.2. BRAZIL MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 24
CHAP 9. COMPETITIVE LANDSCAPE 25
9.1. ABBOTT LABORATORIES 26
9.1.1. COMPANY OVERVIEW 26
9.1.2. FINANCIAL PERFORMANCE 26
9.1.3. PRODUCT BENCHMARKING 26
9.1.4. STRATEGIC INITIATIVES 26
9.2. BECKMAN COULTER, INC. 26
9.2.1. COMPANY OVERVIEW 26
9.2.2. FINANCIAL PERFORMANCE 26
9.2.3. PRODUCT BENCHMARKING 26
9.2.4. STRATEGIC INITIATIVES 26
9.3. DANAHER CORPORATION 26
9.3.1. COMPANY OVERVIEW 26
9.3.2. FINANCIAL PERFORMANCE 26
9.3.3. PRODUCT BENCHMARKING 26
9.3.4. STRATEGIC INITIATIVES 26
9.4. ELITECH GROUP 26
9.4.1. COMPANY OVERVIEW 26
9.4.2. FINANCIAL PERFORMANCE 26
9.4.3. PRODUCT BENCHMARKING 26
9.4.4. STRATEGIC INITIATIVES 26
9.5. F. HOFFMANN-LA ROCHE LTD. 26
9.5.1. COMPANY OVERVIEW 26
9.5.2. FINANCIAL PERFORMANCE 26
9.5.3. PRODUCT BENCHMARKING 26
9.5.4. STRATEGIC INITIATIVES 26
9.6. HITACHI LTD. 26
9.6.1. COMPANY OVERVIEW 26
9.6.2. FINANCIAL PERFORMANCE 27
9.6.3. PRODUCT BENCHMARKING 27
9.6.4. STRATEGIC INITIATIVES 27
9.7. HORIBA, LTD. 27
9.7.1. COMPANY OVERVIEW 27
9.7.2. FINANCIAL PERFORMANCE 27
9.7.3. PRODUCT BENCHMARKING 27
9.7.4. STRATEGIC INITIATIVES 27
9.8. JOHNSON & JOHNSON 27
9.8.1. COMPANY OVERVIEW 27
9.8.2. FINANCIAL PERFORMANCE 27
9.8.3. PRODUCT BENCHMARKING 27
9.8.4. STRATEGIC INITIATIVES 27
9.9. MINDRAY MEDICAL INTERNATIONAL LIMITED 27
9.9.1. COMPANY OVERVIEW 27
9.9.2. FINANCIAL PERFORMANCE 27
9.9.3. PRODUCT BENCHMARKING 27
9.9.4. STRATEGIC INITIATIVES 27
9.10. NOVA BIOMEDICAL CORPORATION 27
9.10.1. COMPANY OVERVIEW 27
9.10.2. FINANCIAL PERFORMANCE 27
9.10.3. PRODUCT BENCHMARKING 27
9.10.4. STRATEGIC INITIATIVES 27
9.11. ORTHO-CLINICAL DIAGNOSTICS, INC. 27
9.11.1. COMPANY OVERVIEW 27
9.11.2. FINANCIAL PERFORMANCE 27
9.11.3. PRODUCT BENCHMARKING 27
9.11.4. STRATEGIC INITIATIVES 27
9.12. RANDOX LABORATORIES LTD. 28
9.12.1. COMPANY OVERVIEW 28
9.12.2. FINANCIAL PERFORMANCE 28
9.12.3. PRODUCT BENCHMARKING 28
9.12.4. STRATEGIC INITIATIVES 28
9.13. ROCHE 28
9.13.1. COMPANY OVERVIEW 28
9.13.2. FINANCIAL PERFORMANCE 28
9.13.3. PRODUCT BENCHMARKING 28
9.13.4. STRATEGIC INITIATIVES 28
9.14. SIEMENS AG 28
9.14.1. COMPANY OVERVIEW 28
9.14.2. FINANCIAL PERFORMANCE 28
9.14.3. PRODUCT BENCHMARKING 28
9.14.4. STRATEGIC INITIATIVES 28
9.15. THERMO FISHER SCIENTIFIC INC. 28
9.15.1. COMPANY OVERVIEW 28
9.15.2. FINANCIAL PERFORMANCE 28
9.15.3. PRODUCT BENCHMARKING 28
9.15.4. STRATEGIC INITIATIVES 28
TABLE 1 GLOBAL CLINICAL CHEMISTRY MARKET BY APPLICATION 2012-2022 ($ MILLION) 29
TABLE 2 GLOBAL TRANSPORTATION MARKET 2012-2022 ($ MILLION) 29
TABLE 3 GLOBAL BUS/RAIL MARKET 2012-2022 ($ MILLION) 29
TABLE 4 GLOBAL MARINE MARKET 2012-2022 ($ MILLION) 29
TABLE 5 GLOBAL SKYLIGHT MARKET 2012-2022 ($ MILLION) 29
TABLE 6 GLOBAL WINDOWS MARKET 2012-2022 ($ MILLION) 29
TABLE 7 GLOBAL AUTOMOTIVE MARKET 2012-2022 ($ MILLION) 29
TABLE 8 GLOBAL REAR-VIEW MIRRORS MARKET 2012-2022 ($ MILLION) 29
TABLE 9 GLOBAL WINDSHIELDS MARKET 2012-2022 ($ MILLION) 29
TABLE 10 GLOBAL SUNROOFS MARKET 2012-2022 ($ MILLION) 29
TABLE 11 GLOBAL WINDOWS MARKET 2012-2022 ($ MILLION) 29
TABLE 12 GLOBAL AEROSPACE MARKET 2012-2022 ($ MILLION) 29
TABLE 13 GLOBAL EXIT DOORS MARKET 2012-2022 ($ MILLION) 29
TABLE 14 GLOBAL DIMMABLE WINDOWS MARKET 2012-2022 ($ MILLION) 29
TABLE 15 GLOBAL ELECTRONICS MARKET 2012-2022 ($ MILLION) 29
TABLE 16 GLOBAL ARCHITECTURAL MARKET 2012-2022 ($ MILLION) 29
TABLE 17 GLOBAL COMMERCIAL MARKET 2012-2022 ($ MILLION) 29
TABLE 18 GLOBAL RETAIL MARKET 2012-2022 ($ MILLION) 29
TABLE 19 GLOBAL PROJECTION SCREENS MARKET 2012-2022 ($ MILLION) 29
TABLE 20 GLOBAL ADVERTISING DISPLAY MARKET 2012-2022 ($ MILLION) 29
TABLE 21 GLOBAL CORPORATE MARKET 2012-2022 ($ MILLION) 29
TABLE 22 GLOBAL EDUCATIONAL BUILDINGS MARKET 2012-2022 ($ MILLION) 29
TABLE 23 GLOBAL HEALTHCARE & LAB FACILITIES MARKET 2012-2022 ($ MILLION) 29
TABLE 24 GLOBAL ISOLATION SCREENS MARKET 2012-2022 ($ MILLION) 30
TABLE 25 GLOBAL EXTERNAL WINDOWSMARKET 2012-2022 ($ MILLION) 30
TABLE 26 GLOBAL RESIDENTIAL MARKET 2012-2022 ($ MILLION) 30
TABLE 27 GLOBAL POWER GENERATION PLANT (SOLAR) MARKET 2012-2022 ($ MILLION) 30
TABLE 28 GLOBAL OTHERS MARKET 2012-2022 ($ MILLION) 30
TABLE 29 GLOBAL SUNGLASS MARKET 2012-2022 ($ MILLION) 30
TABLE 30 GLOBAL GOVERNMENT MARKET 2012-2022 ($ MILLION) 30
TABLE 31 GLOBAL MUSEUM ARTWORK EXPOSITION MARKET 2012-2022 ($ MILLION) 30
TABLE 32 GLOBAL CLINICAL CHEMISTRY MARKET BY TECHNOLOGY 2012-2022 ($ MILLION) 30
TABLE 33 GLOBAL ACTIVE GLASS MARKET 2012-2022 ($ MILLION) 30
TABLE 34 GLOBAL ELECTROCHROMIC SMART GLASS MARKET 2012-2022 ($ MILLION) 30
TABLE 35 GLOBAL MICRO-BLINDS SMART GLASS MARKET 2012-2022 ($ MILLION) 30
TABLE 36 GLOBAL LIQUID CRYSTALS (LCS)/POLYMER DISPERSES LIQUID CRYSTALS (PDLCS)SMART GLASS MARKET 2012-2022 ($ MILLION) 30
TABLE 37 GLOBAL NANOCRYSTALS SMART GLASS MARKET 2012-2022 ($ MILLION) 30
TABLE 38 GLOBAL SUSPENDED PARTICLE DEVICE SMART GLASS MARKET 2012-2022 ($ MILLION) 30
TABLE 39 GLOBAL PASSIVE GLASS MARKET 2012-2022 ($ MILLION) 30
TABLE 40 GLOBAL THERMOCHROMIC SMART GLASS MARKET 2012-2022 ($ MILLION) 30
TABLE 41 GLOBAL PHOTOCHROMIC GLASS SMART GLASS MARKET 2012-2022 ($ MILLION) 30
TABLE 42 GLOBAL LOW-E GLASS MARKET 2012-2022 ($ MILLION) 30
TABLE 43 GLOBAL OTHERS GLASS MARKET 2012-2022 ($ MILLION) 30
TABLE 44 GLOBAL 3D GORILLA GLASS MARKET 2012-2022 ($ MILLION) 30
TABLE 45 GLOBAL PHOTOVOLTAIC & OLED LIGHTING GLASS MARKET 2012-2022 ($ MILLION) 31
TABLE 46 GLOBAL SMART CONTROLS FOR SMART GLASS MARKET 2012-2022 ($ MILLION) 31
TABLE 47 GLOBAL CLINICAL CHEMISTRY MARKET, REGIONAL OUTLOOK 2012-2022 ($ MILLION) 31
TABLE 48 GLOBAL CLINICAL CHEMISTRY MARKET BY REGION 2012-2022 ($ MILLION) 31
TABLE 49 NORTH AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 31
TABLE 50 NORTH AMERICA MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 31
TABLE 51 NORTH AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 31
TABLE 52 U.S. MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 31
TABLE 53 U.S. MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 31
TABLE 54 CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 31
TABLE 55 CANADA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 31
TABLE 56 EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 31
TABLE 57 EUROPE MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 31
TABLE 58 EUROPE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 31
TABLE 59 GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 31
TABLE 60 GERMANY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 31
TABLE 61 UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 31
TABLE 62 UK MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 32
TABLE 63 FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 32
TABLE 64 FRANCE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 32
TABLE 65 SPAIN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 32
TABLE 66 SPAIN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 32
TABLE 67 RUSSIA MARKET ESTIMATES AND FORECAST2012-2022($MILLION) 32
TABLE 68 OTHERS MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022($MILLION) 32
TABLE 69 ASIA PACIFIC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 32
TABLE 70 ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 32
TABLE 71 ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 32
TABLE 72 CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 32
TABLE 73 CHINA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 32
TABLE 74 INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 32
TABLE 75 INDIA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 32
TABLE 76 JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 32
TABLE 77 JAPAN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($MILLION) 32
TABLE 78 OTHER MARKET ESTIMATES AND FORECASTS 2012-2022($MILLION) 33
TABLE 79 OTHER MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022($MILLION) 33
TABLE 80 MIDDLE EAST & AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 33
TABLE 81 MIDDLE EAST & AFRICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 33
TABLE 82 LATIN AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 33
TABLE 83 LATIN AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 33
TABLE 84 BRAZIL MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 33
TABLE 85 BRAZIL MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 33
FIGURE 1 MARKET SHARE BY REGIONS 34
FIGURE 2 UNITED STATES MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 34
FIGURE 3 CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 34
FIGURE 4 EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 34
FIGURE 5 GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 34
FIGURE 6 UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 34
FIGURE 7 FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 34
FIGURE 8 SPAIN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 34
FIGURE 9 REST OF EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 35
FIGURE 10 APAC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 35
FIGURE 11 CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 35
FIGURE 12 INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 35
FIGURE 13 JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 35
FIGURE 14 MIDDLE EAST & AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 35
FIGURE 15 LATIN AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 35
FIGURE 16 BRAZIL MARKET ESTIMATES AND FORECAST 2012-2022($MILLION) 35
Choose License
Contact Information
: sales@briskinsights.com
: +448081890034 (UK)